Stan Kladko, former CTO of SKALE Labs and current SKALE Foundation board member, has proposed adding three engineers to the foundation's board. He argues that engineers who build and maintain the network should help guide decisions on the protocol’s roadmap, grants, and economics, citing examples like Ethereum and Cosmos where engineers participate in governance. The proposal aims to bring technical expertise to long-term decision-making. Kladko has formally submitted this proposal and encourages community support from validators, delegators, and tokenholders.
The former SKALE Labs CTO's proposal for new foundation board seats offers context for readers interested in governance changes. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 19, 2026 16:01 WIB: out of 50 major cryptocurrencies, 37 rose and 11 fell today. Curve DAO Token (CRV) gained 5.16% to Rp6.405 with a typical hold time of 62 days and a buy majority of 57%, contrasting with Uniswap (UNI) which rose 2.94% to Rp133.479 but saw 86% sell orders. Solana (SOL) increased 2.79% to Rp1.898.716, with a more balanced order split of 52% sell and 48% buy and the longest hold time of 71 days among the three.
Nyxoah announced preliminary Q3 2026 revenue of €9.2 million, up 19% sequentially, driven by a 29% increase in U.S. sales. The company submitted a PMA supplement to the FDA to expand its Genio device indication for patients with complete concentric c...
ASML Holding N.V. announced recent transactions under its ongoing share buyback program, repurchasing a total of 233,867 shares between October 12 and October 16, 2026. The shares were bought back at weighted average prices ranging from €1,444.83 to ...
The Phase 3 ALKIVIA trial demonstrated that efgartigimod significantly improves symptoms in patients with autoimmune myositis, including immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM). Patients showed meaningful clinical improve...
In 2025, Berkshire Hathaway, led by Greg Abel, received $479 million in dividends from its $1.3 billion investment in American Express. This highlights the value of holding strong dividend-paying stocks for steady income. Retail investors can apply s...
Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...
